U.S. Stem Cell (OTCMKTS:USRM – Get Free Report) and FOXO Technologies (NYSE:FOXO – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends and analyst recommendations. Insider and Institutional Ownership 31.6% of […]